Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The association between total homocysteine and blood pressure in two independent Chinese populations

Abstract

Hypertension and hyperhomocystinemia have a joint effect on the risk of stroke. We aimed to evaluate the relationship between plasma total homocysteine (tHcy) and blood pressure in two independent Chinese populations. Four thousand five hundred and fifty-five participants who underwent health examinations between March 2016 and September 2016 at Peking University First Hospital were enrolled as ‘Population 1’, and 2689 participants who were admitted to Peking University First Hospital between January 2014 and December 2015 were enrolled as ‘Population 2’. None of the study participants were taking antihypertensive medication or vitamins, or had cardio-cerebrovascular disease or chronic kidney disease stages 4 or 5. In Population 1, a 5 μmol/L increase in tHcy was associated with a 0.47 mmHg (95% confidence interval [CI]: 0.23–0.70 mmHg, p < 0.01) increase in systolic blood pressure (SBP) and a 0.14 mmHg (95% CI: −0.02 to 0.30 mmHg, p = 0.08) increase in diastolic blood pressure (DBP). In Population 2, a 5 μmol/L increase in tHcy was associated with a 0.42 mmHg (95% CI: 0.13–0.72 mmHg, p < 0.01) increase in SBP and a 0.29 mmHg (95% CI: 0.09–0.49 mmHg, p < 0.01) increase in DBP. The prevalence of hypertension was significantly higher in Population 1 (by 47%; odds ratio [OR] 1.47, 95% CI: 1.09–1.98, p = 0.01) and in Population 2 (by 55%;OR 1.55, 95% CI: 1.15–2.08, p < 0.01) in participants with tHcy ≥ 15 μmol/l than in those with tHcy < 10 μmol/L. Stratified analysis showed that the association was stronger in women than in men.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chen Weiwei, Gao Runlin, Liu Lisheng, Zhu Manlu, Wang Wen, Wang Yongjun, et al. China cardiovascular diseases report 2017:a summary. Chin Circulation J. 2018;01:1–8.

    Google Scholar 

  2. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–81.

    Article  CAS  Google Scholar 

  3. Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298:153–7.

    Article  CAS  Google Scholar 

  4. Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in chinese adults: a prospective, nested case-control study. J Transl Int Med. 2015;3:171–8.

    Article  Google Scholar 

  5. Hu DY, Xu XP. Prevention of stroke relies on valid control “H” type hypertension. Zhonghua Nei Ke Za Zhi. 2008;47:976–7.

    PubMed  Google Scholar 

  6. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 2003;19:217–46.

    Article  Google Scholar 

  7. Xu X, Li J, Sheng W, Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis. 2008;26:48–62.

    Article  Google Scholar 

  8. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr. 2007;137:407–13.

    Article  CAS  Google Scholar 

  9. Sen U, Mishra PK, Tyagi N, Tyagi SC. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys. 2010;57:49–58.

    Article  CAS  Google Scholar 

  10. Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 1997;96:1745–9.

    Article  CAS  Google Scholar 

  11. Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2002;156:1105–13.

    Article  Google Scholar 

  12. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Heshmat R, Nouri M, Shafaee A, et al. Plasma homocysteine concentration and blood pressure in healthy Iranian adults: the Tehran Homocysteine Survey (2003|[ndash]|2004). J Hum Hypertens. 2005;19:869–76.

    Article  CAS  Google Scholar 

  13. Li Z, Guo X, Chen S, Zheng L, Yang H, Sun G, et al. Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China. J Hum Hypertens. 2016;30:508–12.

    Article  CAS  Google Scholar 

  14. Qin X, Li Y, Sun N, Wang H, Zhang Y, Wang J, et al. Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients. Arterioscler Thromb Vasc Biol. 2017;37:166–72.

    Article  CAS  Google Scholar 

  15. Wu H, Wang B, Ban Q, Chen L, Yan D, Yu Y, et al. Association of total homocysteine with blood pressure in a general population of Chinese adults: a cross-sectional study in Jiangsu province, China. BMJ Open. 2018;8:e021103.

    Article  Google Scholar 

  16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

    Article  Google Scholar 

  17. Jin M, Wang F, Uthup M, Szydlowska M. Analytical performance of an enzymatic cycling method for total homocysteine measurement. Clin Chim Acta. 2009;399:119–20.

    Article  CAS  Google Scholar 

  18. Dou C, Xia D, Zhang L, Chen X, Flores P, Datta A, et al. Development of a novel enzymatic cycling assay for total homocysteine. Clin Chem. 2005;51:1987–9.

    Article  CAS  Google Scholar 

  19. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526.

    Article  Google Scholar 

  20. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens. 2005;23:2127–43.

    Article  CAS  Google Scholar 

  21. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.

    Article  CAS  Google Scholar 

  22. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–93.

    PubMed  Google Scholar 

  23. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.

    Article  Google Scholar 

  24. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Investig. 2000;106:483–91.

    Article  CAS  Google Scholar 

  25. Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharm. 2002;2:121–5.

    Article  CAS  Google Scholar 

  26. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Liu X, et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood. 2007;110:3648–55.

    Article  CAS  Google Scholar 

  27. Duan L, Hu J, Xiong X, Liu Y, Wang J. The role of DNA methylation in coronary artery disease. Gene. 2018;646:91–7.

    Article  CAS  Google Scholar 

  28. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem. 2001;82:491–500.

    Article  CAS  Google Scholar 

  29. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arteriosclerosis Thrombosis Vasc Biol. 1997;17:2074–81.

    Article  CAS  Google Scholar 

  30. Macdonald TM. Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction. J Hum Hypertens. 2002;16:411–5.

    Article  Google Scholar 

  31. van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 2001;21:2072–9.

    Article  Google Scholar 

  32. Mcmahon JA, Skeaff CM, Williams SM, Green TJ. Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr. 2007;137:1183.

    Article  CAS  Google Scholar 

  33. Yun J, Kim JY, Kim OY, Jang Y, Chae JS, Kwak JH, et al. Associations of plasma homocysteine level with brachial-ankle pulse wave velocity, LDL atherogenicity, and inflammation profile in healthy men. Nutr Metabol Cardiovasc Dis. 2011;21:136–43.

    Article  CAS  Google Scholar 

  34. Pruijm M, Vollenweider P, Mooser V, Paccaud F, Preisig M, Waeber G, et al. Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study. J Hum Hypertens. 2013;27:169–75.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mark Cleasby, PhD, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.

Funding

This research was funded by a Scientific Research Seed Fund of Peking University First Hospital (2018SF074).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yong Huo or Jianping Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weng, H., Li, Y., Fan, F. et al. The association between total homocysteine and blood pressure in two independent Chinese populations. J Hum Hypertens 34, 657–665 (2020). https://doi.org/10.1038/s41371-019-0288-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-019-0288-6

This article is cited by

Search

Quick links